RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Return
18.15%
This Quarter Return
+32.75%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.01B
AUM Growth
+$314M
(+45%)
Cap. Flow
+$162M
Cap. Flow
% of AUM
16%
Top 10 Holdings %
Top 10 Hldgs %
64.85%
Holding
53
New
6
Increased
8
Reduced
14
Closed
16
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$113M |
| 2 |
Aclaris Therapeutics
ACRS
|
$69.1M |
| 3 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$20.4M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$19.6M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$16.6M |
Top Sells
| 1 |
Collegium Pharmaceutical
COLL
|
$19.1M |
| 2 |
BLUE
bluebird bio
BLUE
|
$14.3M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12.6M |
| 4 |
Ardelyx
ARDX
|
$8.93M |
| 5 |
TherapeuticsMD
TXMD
|
$8.9M |
Sector Composition
| 1 | Healthcare | 84.51% |